Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1
Karina S Krings, Judith Hatzfeld, Sandra Weller, Nadine Borkowski, Tanya R Llewellyn, Laura Schmitt, Bo Scherer, Harri M Itkonen, Christoph Peter, Björn Stork, Stefanie Geyh, Jan Eickhoff, Bert Klebl, Nan Qin, Frank Essmann, Sebastian Wesselborg · 2026
Read Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1 by Karina S Krings, Judith Hatzfeld, Sandra Weller, Nadine Borkowski, Tanya R Llewellyn, Laura Schmitt, Bo Scherer, Harri M Itkonen, Christoph Peter, Björn Stork, Stefanie Geyh, Jan Eickhoff, Bert Klebl, Nan Qin, Frank Essmann, Sebastian Wesselborg (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13216340.txt.
Description
Karina S. Krings and co-authors present a 2026 cell study sorting out which kinase-blocking drugs actually kill cancer cells, and why. Many such drugs target cyclin-dependent kinases, the enzymes that drive the cell cycle and gene transcription.
Testing inhibitors in leukaemia and lymphoma cell lines, the team found that blocking the cell-cycle kinases did not kill the cells, and neither did blocking CDK7. Killing came only from blocking CDK9 or CDK12/13, the kinases that keep gene transcription elongating. Those drugs rapidly drained two short-lived protective proteins, Mcl1 and Bfl1/A1, unleashing the cell's death machinery. Combining the two drug types was synergistic. The authors highlight the pair as promising against tumours that hide behind the protective protein Bcl-2.
Catalog record
| CREATOR | Karina S Krings, Judith Hatzfeld, Sandra Weller, Nadine Borkowski, Tanya R Llewellyn, Laura Schmitt, Bo Scherer, Harri M Itkonen, Christoph Peter, Björn Stork, Stefanie Geyh, Jan Eickhoff, Bert Klebl, Nan Qin, Frank Essmann, Sebastian Wesselborg |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 76 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |